Ivanko80In a Monday letter from the commissioner of the U.S. Food and Drug Administration (FDA) to the American College of Obstetricians and Gynecologists, the FDA announced it would “exercise enforcement discretion” on its regulations of the abortion pill.
Yesterday’s policy change comes after a December 2021 change that permanently lifted the requirement for patients to obtain mifepristone during in-person appointments with a physician.